Evidence map›Paper›PMID 39223528›Full record

ArticleBMC veterinary research2024

Molecular evidence of hepatozoonosis in tigers of Vidarbha region of Maharashtra State of India.

S M Kolangath, M D Pawshe, S V Upadhye, V M Dhoot, M S Patil, R M Kolangath

Abstract read
In one paragraph

Article in BMC veterinary research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. International journal for parasitology. Parasites and wildlife · 2025
    Article
  3. Molecular detection and characterization of haemoparasites in captive tigers (Current research in parasitology & vector-borne diseases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

S M KolangathWildlife Research & Training Centre, Maharashtra Animal & Fishery Sciences University, Opp. Hindustan Lever Godown Square, Mahurzhari Road, Gorewada, Nagpur, Fetri, Nagpur, Maharashtra, 441501, India. sujitkolangath@mafsu.in.
M D PawsheWildlife Research & Training Centre, Maharashtra Animal & Fishery Sciences University, Opp. Hindustan Lever Godown Square, Mahurzhari Road, Gorewada, Nagpur, Fetri, Nagpur, Maharashtra, 441501, India.
S V UpadhyeWildlife Research & Training Centre, Maharashtra Animal & Fishery Sciences University, Opp. Hindustan Lever Godown Square, Mahurzhari Road, Gorewada, Nagpur, Fetri, Nagpur, Maharashtra, 441501, India.
V M DhootWildlife Research & Training Centre, Maharashtra Animal & Fishery Sciences University, Opp. Hindustan Lever Godown Square, Mahurzhari Road, Gorewada, Nagpur, Fetri, Nagpur, Maharashtra, 441501, India.
M S PatilNagpur Veterinary College, Seminary Hills, Nagpur, 440013, India.
R M KolangathDepartment of Biotechnology & Biochemistry, Saint Francis DeSales College, Seminary Hills, Nagpur, 440006, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatozoonosis has been reported in many species around the world. Few incidences have been reported in various species of wild felids. Tigers are endangered large cats and are protected under the Wildlife Protection Act, 1972 under Schedule I. The study was carried out to estimate the positivity rate of hepatozoonosis in tigers of the Vidarbha region of Maharashtra, India.

methodsBlood (n = 21) or tissue samples (n = 5) were collected from 26 wild captured / zoo-born or dead tigers during the quarantine period/post-mortem examination. Blood smear examination along with Polymerase Chain Reaction (PCR) studies were conducted for the detection of hepatozoonosis. All the amplicons from the positive samples were purified and sequenced, and the sequences were subjected to nBLAST analysis to detect the species of Hepatozoon. The sequences were deposited into public domain database of National Center for Biotechnology Information (NCBI) and accession numbers were allotted. A phylogenetic study was undertaken to understand the evolutionary lineage of the pathogen. Tissue distribution studies were carried out on tissue samples received during post mortem. A clinical case in a tiger cub was managed and sub-clinical cases were monitored for relapse. Age-wise, sex-wise, region-wise and captive time-wise positivity rate was estimated. The data was analyzed using statistical tools.

resultsA total of 12 tigers were found positive for H. felis during the screening. A clinical case was diagnosed and successfully treated. The age group of 0-3 years reported a positivity rate of 66.66%, and all the cases found positive were reported between the age group of 0-7 years. Males reported a positivity rate of 58.33 per cent, while females reported 35.71%. Taboba and Andhari Tiger Reserve of the state had a positivity rate of 52.94 per cent. However, the statistical analysis for blood parameters and positivity rate by 't' test and Chi-squared test were found to be non-significant.

conclusionsAn overall positivity rate of 46.15% indicates the wide distribution of hepatozoonosis among wild tigers of the Vidarbha region of Maharashtra, India, which is strategically important considering the gene flow and migration of tigers. Hepatozoonosis can progress to clinical outcomes in young animals and require veterinary intervention. Molecular tools and phylogenetic studies can supplement important data on circulating species of Hepatozoon in the field. Further studies on the clinical management and epidemiology of the infection in wild felids will comprehend the cause of wildlife conservation.

Indexed as

CoccidiosisPhylogenyTigersAnimalsEucoccidiidaFemaleIndiaMalePolymerase Chain ReactionHepatozoon felisHepatozoonosisIndiaMaharashtraProtozoanThreatTicksTigerTiger conservationWildlife

Identifiers

PMID39223528
PMCPMC11367827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.